Shares of Tactile Systems Tech TCMD were unchanged at $48.72 after the company reported Q1 results.
Quarterly Results
Earnings per share were down 187.50% over the past year to ($0.07), which missed the estimate of ($0.02).
Revenue of $43,675,000 higher by 16.10% year over year, which beat the estimate of $43,580,000.
Looking Ahead
Tactile Systems Tech hasn't issued any earnings guidance for the time being.
Revenue guidance hasn't been issued by the company for now.
Conference Call Details
Date: May 04, 2020
Time: 12:04 PM ET
Webcast URL: https://edge.media-server.com/mmc/p/cma8rsdc
Price Action
52-week high: $71.65
52-week low: $29.47
Price action over last quarter: down 7.55%
Company Description
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
